CHIP is found in only about 15% of patients (Table 1) with CP-CML at diagnosis, and it is mainly related to ASXL1, DNMT3A or TET2 gene mutations. This evidence concerns the gene TET2 and chronic myelogenous leukemia, BCR-ABL1 positive.